跳至主要内容
临床试验/NCT01045785
NCT01045785Unknown不适用

Investigation of Platelet Function and Aspirin Resistance in Chronic Dialysis Patient

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
300
试验地点
1
主要终点
cardiovascular event, bleeding event,and thrombosis

研究概览

简要总结

The purpose of this study is to determine whether aspirin resistance has impact on cardiovascular event in dialysis patient.

详细描述

Dialysis patient inevitably suffered from uremic bleeding although improvement of dialysis care in the past decades. Physicians used to check bleeding time as a surrogate marker for uremic bleeding. However, bleeding time isn't accurate and as well known, is poorly correlated with clinical bleeding such as surgical bleeding. Platelet function assay (PFA) is a newly developed method to measure platelet aggregation in vitro and is validated in many sorts of platelet disorders. Recently, PFA was also used to evaluate aspirin responsiveness in patients who had taken aspirin. Our study is aim to investigate uremic thrombocytopathy via PFA of dialysis patient in Taiwan. Furthermore, we will study aspirin resistance in dialysis patient.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • dialysis >3 months
  • Hb>10 g/dl & Plt > 10000

排除标准

  • using medication which interfere PFA except aspirin
  • terminal disease such as malignancy
  • active vasculitis

结局指标

主要结局

cardiovascular event, bleeding event,and thrombosis

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验